Shifts in technology drive ACR's guideline changes

Article

The increased utilization of CT, MR, and PET imaging has prompted the American College of Radiology to revise its Appropriateness Criteria manual. Advances in technology enable the ACR to use a robust search engine for its Web-based version. A PDA-based application is also in the works.

The increased utilization of CT, MR, and PET imaging has prompted the American College of Radiology to revise its Appropriateness Criteria manual. Advances in technology enable the ACR to use a robust search engine for its Web-based version. A PDA-based application is also in the works.

The latest updates to the manual provide a more intuitive format overall. This includes the modality utilization ranking tables at the top of each category and a more consistent terminology. The standard term "CT," for example, replaces alternative references such as CAT scan and computed tomography, said Christine Waldrip, appropriateness criteria program specialist.

"We did not add new topics but updated 55 of the existing ones. These now include some of the more recent technologies," Waldrip said.

A few examples of indications that reflect technology advances are lung cancer staging and workup of solitary pulmonary nodules, uterine cancer, blunt chest trauma and suspected aortic injury, acute trauma of the hand or wrist, and acute pyelonephritis.

Many topics had not been reviewed since 1999. In some cases, only minor editorial modifications were made. But in many others, panel experts had to address the substantive evolution that has affected imaging modalities and their applications.

"CT urography has revolutionized the workup of hematuria, stone disease, and renal cancer staging in many practices. These changes are reflected now in the guidelines," said Dr. Peter L. Choyke, chief of the molecular imaging program at the National Cancer Institute and chair of the Appropriateness Criteria's urology panel.

FDG-PET wasn't even on the list for many illnesses five years ago, and now it is considered a reasonable diagnostic method in many conditions, Choyke said.

A PDA-based version will be launched soon. It's logical, Choyke said, to migrate to handheld devices, which can be updated every day.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.